| INTC |
Report |
Q2 Revenue |
BEAT |
pred ~$14.65B vs. cons $14.43B |
MEDIUM |
| INTC |
Report |
Q2 non-GAAP EPS |
BEAT |
pred ~$0.24 vs. cons $0.223 |
MEDIUM |
| INTC |
Report |
Q2 DCAI revenue ex-Altera |
BEAT |
pred ~$5.75B vs. cons $5.59B |
MEDIUM |
| INTC |
Guide |
Q3 Revenue |
BETTER |
guide midpoint ~$15.3B vs. cons $15.11B |
LOW |
| INTC |
Guide |
Q3 non-GAAP EPS |
BETTER |
guide ~$0.30 vs. cons $0.279 |
LOW |
| INTC |
Guide |
Q3 non-GAAP gross margin |
UNCHANGED |
guide ~40.5% vs. cons ~40.3% |
LOW |
| INTC |
Return |
Day-1 residual (stock − beta × S&P 500) |
+6.0% |
— |
LOW |
| INTC |
Return |
5-day cumulative residual |
+8.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — Q3 estimates rise |
LOW |